Thomas S, Morrison A, Morton G, Roberts P, Clark V, Imrie J
Orphanet J Rare Dis. 2024; 19(1):87.
PMID: 38403596
PMC: 10895743.
DOI: 10.1186/s13023-023-03001-z.
Kubek L, Claus B, Zernikow B, Wager J
BMC Palliat Care. 2024; 23(1):52.
PMID: 38395866
PMC: 10885472.
DOI: 10.1186/s12904-024-01394-7.
Thomas R, Pesut B, Siden H, Treschow M, Puurveen G
Palliat Care Soc Pract. 2023; 17:26323524231209060.
PMID: 37954463
PMC: 10634257.
DOI: 10.1177/26323524231209060.
Kubek L, Kutz P, Roll C, Zernikow B, Wager J
J Clin Med. 2022; 11(23).
PMID: 36498681
PMC: 9739292.
DOI: 10.3390/jcm11237107.
Chiu A, Wong S, Wong N, Wong W, Tso W, Fung C
Orphanet J Rare Dis. 2022; 17(1):334.
PMID: 36056400
PMC: 9437405.
DOI: 10.1186/s13023-022-02485-5.
Home-Based Care for Children with Serious Illness: Ecological Framework and Research Implications.
Boyden J, Hill D, LaRagione G, Wolfe J, Feudtner C
Children (Basel). 2022; 9(8).
PMID: 35892618
PMC: 9330186.
DOI: 10.3390/children9081115.
Towards Understanding Behaviour and Emotions of Children with CLN3 Disease (Batten Disease): Patterns, Problems and Support for Child and Family.
Honingh A, Kruithof Y, Kuper W, van Hasselt P, Sterkenburg P
Int J Environ Res Public Health. 2022; 19(10).
PMID: 35627432
PMC: 9141744.
DOI: 10.3390/ijerph19105895.
A systematic review and integrative sequential explanatory narrative synthesis: The psychosocial impact of parenting a child with a lysosomal storage disorder.
Hassall S, Smith D, Rust S, Wittkowski A
J Inherit Metab Dis. 2022; 45(3):406-416.
PMID: 35124835
PMC: 9305282.
DOI: 10.1002/jimd.12482.
The impact of severe rare chronic neurological disease in childhood on the quality of life of families-a study on MLD and PCH2.
Ammann-Schnell L, Groeschel S, Kehrer C, Frolich S, Krageloh-Mann I
Orphanet J Rare Dis. 2021; 16(1):211.
PMID: 33971942
PMC: 8111977.
DOI: 10.1186/s13023-021-01828-y.
Insights into the Frequency and Distinguishing Features of Sleep Disorders in Pediatric Palliative Care Incorporating a Systematic Sleep Protocol.
Dreier L, Zernikow B, Stening K, Wager J
Children (Basel). 2021; 8(1).
PMID: 33477321
PMC: 7830656.
DOI: 10.3390/children8010054.
A mixed-methods systematic review and meta-analysis of barriers and facilitators to paediatric symptom management at end of life.
Greenfield K, Holley S, Schoth D, Harrop E, Howard R, Bayliss J
Palliat Med. 2020; 34(6):689-707.
PMID: 32228216
PMC: 7521017.
DOI: 10.1177/0269216320907065.
Challenges of palliative care in children with inborn metabolic diseases.
Hoell J, Warfsmann J, Distelmaier F, Borkhardt A, Janssen G, Kuhlen M
Orphanet J Rare Dis. 2018; 13(1):112.
PMID: 29986738
PMC: 6038293.
DOI: 10.1186/s13023-018-0868-5.
Emerging Methodologies in Pediatric Palliative Care Research: Six Case Studies.
Nelson K, Feinstein J, Gerhardt C, Rosenberg A, Widger K, Faerber J
Children (Basel). 2018; 5(3).
PMID: 29495384
PMC: 5867491.
DOI: 10.3390/children5030032.
Pain reporting and analgesia management in 270 children with a progressive neurologic, metabolic or chromosomally based condition with impairment of the central nervous system: cross-sectional, baseline results from an observational, longitudinal....
Friedrichsdorf S, Postier A, Andrews G, Hamre K, Steele R, Siden H
J Pain Res. 2017; 10:1841-1852.
PMID: 28831272
PMC: 5548270.
DOI: 10.2147/JPR.S138153.
Use of buccal morphine in the management of pain in children with life-limiting conditions: Results of a laboratory study.
McCulloch R, Sattar M, Henderson E, Lane M, Bluebond-Langner M
Palliat Med. 2017; 32(2):554-558.
PMID: 28631529
PMC: 5788078.
DOI: 10.1177/0269216317717192.
Parents' experiences of living with, and caring for children, adolescents and young adults with Mucopolysaccharidosis (MPS).
Somanadhan S, Larkin P
Orphanet J Rare Dis. 2016; 11(1):138.
PMID: 27724940
PMC: 5057247.
DOI: 10.1186/s13023-016-0521-0.
Charting the Territory: Children and families living with progressive life-threatening conditions.
Siden H, Steele R
Paediatr Child Health. 2015; 20(3):139-44.
PMID: 25914572
PMC: 4403275.
DOI: 10.1093/pch/20.3.139.
An investigation of the middle and late behavioural phenotypes of Mucopolysaccharidosis Type-III.
Cross E, Grant S, Jones S, Bigger B, Wraith J, Mahon L
J Neurodev Disord. 2015; 6(1):46.
PMID: 25657821
PMC: 4318134.
DOI: 10.1186/1866-1955-6-46.
Clinical trials in rare disease: challenges and opportunities.
Augustine E, Adams H, Mink J
J Child Neurol. 2013; 28(9):1142-50.
PMID: 24014509
PMC: 3964003.
DOI: 10.1177/0883073813495959.
Parental social support, coping strategies, resilience factors, stress, anxiety and depression levels in parents of children with MPS III (Sanfilippo syndrome) or children with intellectual disabilities (ID).
Grant S, Cross E, Wraith J, Jones S, Mahon L, Lomax M
J Inherit Metab Dis. 2012; 36(2):281-91.
PMID: 23151683
DOI: 10.1007/s10545-012-9558-y.